News Category
Onco-Innovations' LOI with Ifowonco could expand its immuno-oncology pipeline, potentially enhancing solid tumor treatments by combining DDR inhibitio...
A new study reveals that nearly 80% of young adults have early signs of cardiovascular-kidney-metabolic syndrome and arterial injury, highlighting the...
Quantum BioPharma's Lucid-MS offers a novel approach to treating multiple sclerosis by targeting myelin degradation and smoldering lesions, potentiall...
A mathematical study proposes a potential solution to melanoma therapy challenges, highlighting implications for cancer immunotherapy.
Quantum BioPharma's Lucid-MS, a first-in-class therapy aimed at protecting myelin without immunosuppression, has received FDA clearance for phase 2 tr...
VERAXA Biotech's collaboration with Ardigen uses AI to optimize its oncology pipeline, potentially reducing development risks and reviving abandoned d...
Scientists have identified a protein on glioblastoma cells that could be targeted to make the cancer more vulnerable to existing treatments, offering ...
NanoViricides is set to begin a Phase II trial of NV-387 Oral Gummies for Ebola in the DRC, potentially offering a more accessible treatment option in...
Cayenne Wellness Center hosts its 20th Annual Sickle Cell Disease Educational Summit, highlighting two decades of progress and ongoing challenges in s...
Helix BioPharma strengthens its leadership with Dr. Loeffler to advance L-DOS47 and LEUMUNA through pivotal clinical milestones, underscoring its comm...
The summit aims to address the unique challenges faced by Hispanic and Latino individuals with sickle cell disease through culturally relevant educati...
The Lung Cancer Foundation of America and the International Association for the Study of Lung Cancer have awarded $200,000 each to two early-career sc...
Maria Cristina Swiman's memoir 'Silence Across Three Continents' recounts a mother's harrowing journey through cultural conflict, legal battles, and i...
A comprehensive review in World Journal of Pediatric Surgery synthesizes operative approaches for necrotizing enterocolitis, emphasizing bowel preserv...
Helix BioPharma Corp. reshapes its board with CEO Thomas Mehrling's appointment and Janusz Grabski's resignation, aiming to align governance with clin...
Onco-Innovations is progressing its precision oncology candidate ONC010 through IND-enabling activities, positioning itself to address biomarker-selec...
Researchers at the University of Manchester discovered that a rare subset of immune cells, previously overlooked, is crucial for initiating and mainta...
Lantern Pharma reported Q2 2026 results highlighting progress in its AI-driven oncology pipeline and the establishment of Open Medicine AI as a separa...
NeOnc's NEO100 shows promising survival benefits in recurrent brain cancer, positioning the company for FDA alignment and a potential registrational p...
As the Bundibugyo Ebola outbreak in the DRC escalates, GeoVax offers its MVA-based vaccine candidates and expertise to support global response efforts...
Kyle Brown's participation in ALS Arizona's Bite Nite gala underscores the law firm's commitment to supporting families affected by ALS through estate...
NanoViricides has received regulatory approval to begin a Phase II trial of its oral antiviral NV-387 for the Bundibugyo ebolavirus outbreak, potentia...
Research at the University of Virginia suggests focused ultrasound could improve brain tumor treatment, offering a less harmful alternative to convent...
Telomir Pharmaceuticals announced peer-reviewed preclinical data showing Telomir-Zn suppresses tumor growth in prostate and triple-negative breast can...
A new narrative review provides a comprehensive framework for risk-adapted treatment of neuroblastoma, emphasizing the integration of clinical, biolog...
Quantum BioPharma is advancing its two-pronged approach to neurological health with the investigational MS therapy Lucid-MS and the supplement unbuzzd...
A Spanish patient initially treated for brain cancer was found to have pork tapeworm cysts, underscoring the importance of proper pork cooking and the...
VERAXA Biotech's VXA-222 bispecific ADC program has moved into the next development stage, and the company has strengthened its IP with new patent fil...
The Keep A Breast Foundation's 2026 High Desert Collection merges art and breast health awareness through community chest casts, opening in Pioneertow...
A new liquid biopsy offers a simpler way to predict which advanced lung cancer patients will respond to immunotherapy, potentially improving treatment...
GeoVax announces completion of manufacturing, regulatory, and preclinical milestones for its GEO-MVA vaccine, supporting the planned Phase 3 immune-br...
Onco-Innovations is advancing a multifaceted approach to cancer treatment by combining PNKP-targeted DDR inhibition, nanoparticle drug delivery, and c...
Researchers at Nagoya University discovered that the ancient protein C3, when produced by tumor cells, can enhance the effectiveness of immunotherapy ...
VolitionRx's new peer-reviewed study validates its Capture-Seq liquid biopsy technology, which isolates over 99% pure circulating tumor DNA, potential...
VERAXA Biotech's VXA-222 bispecific ADC program has moved past discovery, and the company has strengthened its IP with new patent filings, underscorin...
The American Heart Association recognizes over 3,000 hospitals and agencies for their commitment to evidence-based cardiovascular care through Get Wit...
The US surpasses last year's measles case count, reaching a 30-year high, prompting health officials to intensify contact tracing and vaccination camp...
Oncotelic Therapeutics will present at the OTCQB Virtual Investor Conference, showcasing advancements in its clinical trials and proprietary drug deli...
Recent independent research suggests that immune responses from licensed Ebola vaccines may cross-react with other ebolavirus species, reinforcing the...
Amber Dermatology, founded by board-certified dermatologist Dr. Alyssa Miceli, has opened in Trumbull, CT, providing a patient-centered approach to me...
Experts warn that climate change is accelerating the spread of infectious diseases, yet policymakers are not treating this as a serious threat.
VERAXA Biotech strengthens its scientific leadership by appointing Dr. Christoph Erkel as Chief Scientific Officer to advance its proprietary BiTAC® p...
Onco-Innovations closed a CAD$5 million private placement to advance its ONC010 program and SynoGraph platform, highlighting investor confidence in it...
Dr. Lee Newcomer, former Chief Medical Officer of UnitedHealthcare and author of "UNMASKED," has signed with agent Alan Morell at Creative Management ...
A new preclinical study reveals that an experimental treatment containing vitamin B12 could stop the progression of glioblastoma multiforme, the deadl...
VolitionRx announces mounting clinical evidence supporting its Nu.Q NETs assay for sepsis diagnosis and management, potentially enabling personalized ...
VERAXA Biotech (NASDAQ: VRXA) announced the expansion of its patent portfolio with new filings covering its BiTAC-TCE and BiTAC-ADC platforms, securin...
VERAXA Biotech strengthens its scientific leadership with Dr. Christoph Erkel as new CSO, signaling progress in its BiTAC(R) platform and oncology pip...
